Sangge Medical recently released AI risk control system
Recently, Sanggeishi Medical released the Sangge Artificial Intelligence Risk Control System. The system is designed for financial engineering models, using big data calculation methods, cloud storage systems, self-constructed medical and health industry secondary market real-time price index and risk factor analysis database, etc., for professional investment institutions, listed companies, etc. Risk management, investment risk warning, post-investment professional management IT system development and services can reduce the investment cost of investment research database.
Sangge said that "the A-share market is our first step. Next year, the Sangge Information Technology Association will gradually establish all the data of the relevant medical listed companies on the NASDAQ exchange, the New York Stock Exchange and the Hong Kong Stock Exchange. A sample library of industry chain research in the global healthcare industry."
Laboratory Diagnostic,Reagent Strips For Urinalysis,Assay Kits,LETIA Assay Kit,Urinalysis Assay Kits
Jilin Sinoscience Technology Co. LTD , https://www.jilinsinoscience.com